Literature DB >> 10891638

Central nervous system complications in human herpesvirus-6 infection.

T Yoshikawa1, Y Asano.   

Abstract

Human herpesvirus-6 (HHV-6) is the causative agent of the common childhood infectious disease, exanthem subitum. After the virus was recently isolated from humans, it was found to be closely related to human cytomegalovirus (CMV), and was thus classified within the beta subgroup of human herpesviruses. HHV-6 possesses neurotropism in vitro, and it has been suggested that primary infection can cause complications of the central nervous system (CNS), including febrile seizures and encephalitis/encephalopathy. There is also speculation that the direct invasion of the virus into the CNS may play an important role in causing these neurological complications. Moreover, there are several reports which have suggested an association between HHV-6 and a variety of neurological disorders in adults. This paper will briefly review our virological understanding of the virus, and summarize recent findings regarding HHV-6 as an etiologic agent for CNS infection.

Entities:  

Mesh:

Year:  2000        PMID: 10891638     DOI: 10.1016/s0387-7604(00)00113-3

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  22 in total

1.  Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.

Authors:  Katherine N Ward; Hoe Nam Leong; Anton D Thiruchelvam; Claire E Atkinson; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

2.  Acute cerebellitis in primary human herpesvirus-6 infection.

Authors:  Zenichiro Kato; Ryo Kozawa; Takahide Teramoto; Kazuyuki Hashimoto; Shinji Shinoda; Naomi Kondo
Journal:  Eur J Pediatr       Date:  2003-08-26       Impact factor: 3.183

3.  Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis.

Authors:  Elisabetta Caselli; Michela Boni; Arianna Bracci; Antonella Rotola; Claudio Cermelli; Massimiliano Castellazzi; Dario Di Luca; Enzo Cassai
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Variant-specific tropism of human herpesvirus 6 in human astrocytes.

Authors:  Donatella Donati; Elena Martinelli; Riccardo Cassiani-Ingoni; Jenny Ahlqvist; Jean Hou; Eugene O Major; Steve Jacobson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms.

Authors:  M Mayne; C Cheadle; S S Soldan; C Cermelli; Y Yamano; N Akhyani; J E Nagel; D D Taub; K G Becker; S Jacobson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 6.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy.

Authors:  Svetlana Chapenko; Silvija Roga; Sandra Skuja; Santa Rasa; Maksims Cistjakovs; Simons Svirskis; Zane Zaserska; Valerija Groma; Modra Murovska
Journal:  J Neurovirol       Date:  2016-01-04       Impact factor: 2.643

Review 8.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

Review 10.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.